Insufficient scRNA-seq data for expression of TDRKH at single-cell level.
Insufficient scRNA-seq data for expression of TDRKH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1136.09 | 2641 / 2642 | 99% | 12.66 | 699 / 705 |
prostate | 100% | 668.53 | 244 / 245 | 99% | 15.87 | 497 / 502 |
thymus | 100% | 836.78 | 653 / 653 | 98% | 16.91 | 595 / 605 |
breast | 99% | 417.09 | 456 / 459 | 99% | 20.44 | 1104 / 1118 |
bladder | 100% | 291.19 | 21 / 21 | 93% | 11.23 | 468 / 504 |
intestine | 100% | 452.98 | 965 / 966 | 93% | 7.55 | 488 / 527 |
lung | 97% | 420.69 | 562 / 578 | 93% | 14.63 | 1078 / 1155 |
stomach | 99% | 305.89 | 356 / 359 | 91% | 7.78 | 260 / 286 |
pancreas | 97% | 267.79 | 317 / 328 | 91% | 6.50 | 162 / 178 |
adrenal gland | 98% | 367.30 | 254 / 258 | 85% | 11.30 | 196 / 230 |
uterus | 91% | 219.85 | 154 / 170 | 92% | 11.03 | 421 / 459 |
esophagus | 97% | 345.00 | 1404 / 1445 | 80% | 7.15 | 147 / 183 |
skin | 88% | 217.53 | 1599 / 1809 | 88% | 9.48 | 413 / 472 |
kidney | 100% | 394.31 | 89 / 89 | 71% | 4.11 | 640 / 901 |
ovary | 66% | 111.61 | 119 / 180 | 97% | 11.00 | 418 / 430 |
liver | 80% | 207.41 | 181 / 226 | 74% | 6.36 | 301 / 406 |
spleen | 100% | 599.82 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 424.14 | 798 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 347.12 | 1185 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 320.58 | 1311 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.20 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.54 | 27 / 29 |
heart | 89% | 250.55 | 768 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 53% | 152.13 | 495 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.28 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034587 | Biological process | piRNA processing |
GO_0009566 | Biological process | fertilization |
GO_0007283 | Biological process | spermatogenesis |
GO_0030719 | Biological process | P granule organization |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0071546 | Cellular component | pi-body |
GO_0005739 | Cellular component | mitochondrion |
GO_0071547 | Cellular component | piP-body |
GO_0043186 | Cellular component | P granule |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | TDRKH |
Protein name | Tudor and KH domain-containing protein (Tudor domain-containing protein 2) Tudor and KH domain containing (cDNA, FLJ79178, highly similar to Tudor and KH domain-containing protein) Tudor and KH domain containing |
Synonyms | TDRD2 hCG_16924 |
Description | FUNCTION: Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules. . |
Accessions | ENST00000526378.5 E9PKN8 Q5SZR4 ENST00000368825.7 [Q9Y2W6-3] ENST00000458431.6 [Q9Y2W6-2] ENST00000368827.10 [Q9Y2W6-2] ENST00000530202.1 ENST00000368823.5 ENST00000368824.8 [Q9Y2W6-2] B7ZAG4 ENST00000526413.5 ENST00000525790.5 E9PQX4 ENST00000368822.5 [Q9Y2W6-2] Q9Y2W6 |